Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.

V Rajapurohitam1, N Chalhoub, N Benachenhou

  • 1Institut de recherches cliniques de Montréal, Faculté de Médecine de l'Université de Montréal, 110 avenue des Pins Quest, Montréal, Quebec H2W 1R7, Canada.

Bone
|May 10, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous nonsense mutation in SCHIP1/IQCJ-SCHIP1 causes a neurodevelopmental brain malformation syndrome.

Clinical genetics·2017
Same author

Elements for optimizing a one-step enzymatic bio-refinery process of shrimp cuticles: Focus on enzymatic proteolysis screening.

Biotechnology reports (Amsterdam, Netherlands)·2017
Same author

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Leukemia·2017
Same author

Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.

Current medical research and opinion·2017
Same author

Reduced laser-evoked potential habituation detects abnormal central pain processing in painful radiculopathy patients.

European journal of pain (London, England)·2017
Same author

Ethical guidelines for publication of research.

Calcified tissue international·2016

The grey-lethal (gl) mouse mutation causes osteopetrosis by increasing osteoclast numbers. These osteoclasts have defective cytoskeletons and impaired bone resorption, independent of key enzyme deficiencies.

Area of Science:

  • Osteoclast Biology
  • Skeletal Biology
  • Mouse Models of Disease

Background:

  • Osteopetrosis is a rare genetic disorder characterized by impaired bone resorption.
  • The grey-lethal (gl) mouse is a model for malignant autosomal-recessive osteopetrosis in humans.
  • Osteoclasts are crucial for bone remodeling and resorption.

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying the osteopetrotic phenotype in the gl mouse mutant.
  • To characterize the osteoclast abnormalities in gl mice and their impact on bone resorption.

Main Methods:

  • Histological analysis of bone tissue from gl mice.
  • Quantification of tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts.
  • Assessment of osteoclast cytoskeletal organization and ruffled border development.

Related Experiment Videos

  • Pit formation assay to evaluate bone resorption activity.

    • Main Results:

    • Gl mice exhibit a significantly increased number of differentiated, multinucleated osteoclasts.
    • These osteoclasts show defective cytoskeletal reorganization and underdeveloped ruffled borders.
    • Osteoclast bone resorption activity is markedly impaired (four- to tenfold) in gl mice.
    • Key enzymes (V-ATPase, cathepsin-K) and signaling factors (Src, TRAF-6) are not significantly altered in gl osteoclasts.

    Conclusions:

    • The gl mutation leads to an increased number of osteoclasts with functional defects.
    • These defects include impaired cytoskeletal organization and reduced bone resorption, independent of deficiencies in V-ATPase, Src, cathepsin-K, and TRAF-6.
    • The study elucidates a novel mechanism contributing to osteopetrosis in the gl mouse model.